MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03216nam a2200361 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ASIN9814411043 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210816161717.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
150204s2013 si a eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9814411043 (hardcover) |
| Terms of availability |
$149.95 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789814411042 (hardcover) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
EG-NcFUE |
| Description conventions |
rda |
| Original cataloging agency |
EG-NcFUE |
| Language of cataloging |
eng |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Edition number |
23 |
| Classification number |
615.6 |
| Item number |
N |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Nanotechnology for the delivery of therapeutic nucleic acids / |
| Statement of responsibility, etc |
edited by Dan Peer. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Singapore : |
| Name of publisher, distributor, etc |
Pan Stanford Publishing, |
| Date of publication, distribution, etc |
2013. |
| 264 #2 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
London : |
| Name of publisher, distributor, etc |
Taylor & Francis, |
| Date of publication, distribution, etc |
2013. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 226 pages ; |
| Dimensions |
23 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Pan stanford series on biomedical nanotechnology; |
| Volume number/sequential designation |
v. 4. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
pharmacy bookfair2015 |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Lipoplexes and polyplexes : from gene delivery to gene expression / Gerardo Byk, Mirit Cohen-Ohana, and Fiana Mirkin -- 2. Cationic polymers for the delivery of therapeutic nucleotides / Wahid Khan, Saravanan Muthupandian, and Abraham J. Domb -- 3. Membrane/core nanoparticles for delivery of therapeutic nucleic acid / Younjee Chung and Leaf Huang -- 4. Delivery of single siRNA molecules / Caroline Palm-Apergi and Steven F. Dowdy -- 5. Cell-specific aptamer-functionalized RNAi : a new prospect for targeted siRNA delivery / Jiehua Zhou and John J. Rossi -- 6. Bioresponsive nanoparticles for the intracellular delivery of RNAi therapeutics / Kenneth Alan Howard -- 7. Lipid-like delivery materials for efficient siRNA delivery / James Dahlman, Robert Langer, and Michael Goldberg -- 8. Manipulation of leukocytes using therapeutic RNAi delivered by targeted and stabilized nanoparticles / Dan Peer -- 9. Lowering the siRNA delivery barrier : alginate scaffolds and immune stimulation / Jana McCaskill, Sherry Wu, Norliana Khairuddin, and Nigel A.J. McMillan. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Nucleic acid (NA) therapeutics has been extensively studied both in the academia and in the pharmaceutical industry and is still considered the promise for new therapeutic modalities, especially in personalized medicine. The only hurdle that limits the translation of NA therapeutics from an academic idea to the new therapeutic modality is the lack of efficient and safe delivery strategies. Nanotechnology for the Delivery of Therapeutic Nucleic Acids , written by world experts in the field of nanotechnology for NA delivery, the contributing authors bring together the state of the art in delivery strategies with strong emphasis on aspects that are of essence to the pharmaceutical industry, such as stability, general toxicity, immune-toxicity, pharmacokinetics, efficacy, and validation of new drug targets using unique approaches based on exquisite nanotechnology strategies. |
| 650 0# - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug delivery systems. |
| 650 0# - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nucleic acids. |
| 650 0# - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Nanotechnology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Peer, Dan, |
| Dates associated with a name |
1972-, |
| Relator term |
editor. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Pan stanford series on biomedical nanotechnology. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Amazon.com |
| Uniform Resource Identifier |
<a href="http://www.amazon.com/exec/obidos/ASIN/9814411043/chopaconline-20">http://www.amazon.com/exec/obidos/ASIN/9814411043/chopaconline-20</a> |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Abstract |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1742">http://repository.fue.edu.eg/xmlui/handle/123456789/1742</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |